Commodore Capital LP

Holdings History for SAB Biotherapeutics, Inc. - Common Stock, $0.0001 par value per share (SABS)

Symbol: SABS on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Shares Owned: 4,522,977 shares
Security Ownership %: 9.9%

Shares, Excluding Options vs Price

Value, Excluding Options

Commodore Capital LP ownership in SAB Biotherapeutics, Inc. Common Stock, $0.0001 par value per share (SABS)

03 Oct 2025 - Commodore Capital LP has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,522,977 shares of SAB Biotherapeutics, Inc. Common Stock, $0.0001 par value per share (SABS). This represents 9.9% ownership of the company. This is the first filing by Commodore Capital LP disclosing ownership of SAB Biotherapeutics, Inc. Common Stock, $0.0001 par value per share (SABS).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Commodore Capital LP	9.9%		$9,588,711	4,522,977			$2.12	13G	26 Sep 2025	03 Oct 2025, 16:05

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2025	0.43%	+0.43%	$8,847,015	4,401,500	+4,401,500	NEW	$2.01	Q3 2025
30 Jun 2024		-0.06%	$0	0	-183,174	-100%		Q2 2024
31 Mar 2024	0.06%	-0.5%	$831,610	183,174	-1,648,572	-90%	$4.54	Q1 2024
31 Dec 2023	0.11%	+0.11%	$1,259,325	1,831,746	+1,831,746	NEW	$0.6875	Q4 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.